Otilonium Bromide Boosts Antimicrobial Activities of Colistin against Gram-Negative Pathogens and Their Persisters

Scientists identified an FDA-approved drug, Otilonium bromide, which restored the activity of colistin against colistin-resistant Gram-negative bacteria in vitro and in a mouse infection model.
[Communications Biology]
Full Article

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News